Delivery Order SPE2DB22D2009-SPE2DB25FL6BW
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.14 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,559.71 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of March 20, 2024 and was awarded on March 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,661,577 units of febuxostat 40 mg tablets. The award, valued at $2,066.16, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
This federal contract award is a Delivery Order valued at $1,190.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The contract is for the delivery of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat high levels of uric acid in the blood. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,913.99 Firm Fixed Price Delivery Order contract is for the supply of febuxostat 40 mg tablets. The contract is not set aside and is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical through November 2026. This...
This federal contract award, valued at $8,617.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of febuxostat 40 mg tablets and has an ultimate completion date of August 24, 2022. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of febuxostat 40 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,353.01. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,479.78 Firm Fixed Price delivery order is for the supply of 4,565,481,718 units of the prescription medication Febuxostat 40 mg tablets. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of febuxostat 40 mg tablets, a medication used for the treatment of gout. The delivery order has a ceiling value of $3,060.37 and is a Firm Fixed Price contract. The period of performance runs through December 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,338.63 firm fixed-price delivery order is for the supply of Febuxostat 40 mg tablets, with a completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...